Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study

This publication has 28 references indexed in Scilit:

• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
  Diabetes Care, 2012
• IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
  Diabetes Research and Clinical Practice, 2011
• National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
  The Lancet, 2011
• Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review
  Diabetes Care, 2010
• Predictors and Impact of Intensification of Antihyperglycemic Therapy in Type 2 Diabetes
  Diabetes Care, 2009
• 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
  New England Journal of Medicine, 2008
• Treatment Escalation and Rise in HbA1c Following Successful Initial Metformin Therapy
  Diabetes Care, 2006
• Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
  Annals of Internal Medicine, 2004
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
  BMJ, 2000
• Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)
  JAMA, 1999